Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.
September 10, 2014 09:29 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Sept. 10, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that data from EXCITE ISR will be presented as a late-breaking clinical trial at...